Decision Diagnostics Corp (DECN)

[HFM2]

UNTIL THE ABOVE THREE ITEMS HAVE BEEN ADDRESSED, DECN's COVID-19 INITIATIVE IS NOTHING MORE THAN CEO KEITH BERMAN's SMOKE & MIRRORS!

It is science, right? So isn't science all about waiting to see the verified/falsified outcome of a trial before committing too many resources to producing that which has not yet been verified/falsified? No drugs/tests/diagnostics have been recalled for not quite working as well in broad human populations as they did in Phase 3 study groups, right? So, even with good data, the story is not complete. Even after manufacture and with distribution, warnings must be included with all drugs. Of course, DECN needs to address these issues, but that is only saying the obvious.

The FDA definitely has his application and has been in conversation with him/them over the design and testing. Time will shine the brightest light of all into the narrow recesses of the unknown . . . here in this year of perfect vision.